Inhibition of protein opens door to treatment of pancreatic cancer
Tuesday, July 1, 2014 - 20:01
in Health & Medicine
A new protein, galectin-1, has been identified as a possible therapeutic target for pancreatic cancer. For the first time, researchers have demonstrated the effects of the inhibition of this protein in mice suffering this type of cancer and the results showed an increase in survival of 20%. The work further suggests that it could be a therapeutic target with no adverse effects.